Skip to main content

NitroMed, Inc. (NASDAQ: NTMD) Investor Investigation Over Proposed Acquisition As Unfair.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

According to a press release an investigation on behalf of NitroMed, Inc. (NASDAQ: NTMD) investors over possible breaches of fiduciary duty and other violations of state law by the board of directors of NitroMed arising out of their attempt to sell the NitroMed to Deerfield Capital. NitroMed, Inc. (NASDAQ: NTMD) announced that it entered into a merger agreement to be acquired by affi...



You must register (for free) or login to view the entire investigation.